Sanofi's EVP, manufacturing and supply, Brendan O’Callaghan, tells Scrip how modular concept manufacturing at a new site in Singapore can drive efficiencies and minimize downtime, with technologies such as digital twins expected to further improve operational metrics.
Sanofi is redefining its operations with cutting-edge and flexible manufacturing that can switch between products rapidly, augmented by a range of new-age technologies on the shop floor.
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
Adstiladrin sales hit €70m in first full year on the market
Evaluate data show that biopharma companies raising cash in the smallest and largest categories of venture capital financings struggled to meet bars set in prior quarters.
The rollout of Trump’s tariff plan has been a policy whiplash, but despite a 90-day pause on tariffs, it appears the US president is still holding a grudge with industry over drug pricing.
European pharma leaders want to see a deal so that no tariffs are imposed on medicines – but they also want the European Union to urgently rethink its sector policies that they believe will lead to massive investment loss.
Strong sales growth for the German group’s SGLT2 inhibitor in 2024
The firm has lofty ambitions for the aldosterone synthase inhibitor to treat hypertension and kidney disease.
The UK giant is forecasting peak sales of $5bn plus
